Canada approves Lallemand’s probiotic gut-brain axis health claim
Health Canada accepted Probio’Stick’s benefit claims on stress, anxiety, and mood balance, the company announced in a press release.
Probio’Stick’s formula, which contains Lactobacillus helveticus Rosell-52 and Bifidobacterium longum Rosell-175 in a stick format, is marketed to help moderate general feelings of anxiety, promoting healthy mood balance, reduce stress-related gastrointestinal complications, and reduce stress-induced gastrointestinal discomfort.
“This recognition is based on a strong clinical and pre-clinical dossier examining the interactions of our probiotic with the brain-gut axis, or second brain, an area of growing interest for the scientific community and consumers alike and for which we have been dedicated research efforts for nearly a decade,” Solange Henoud, Regulatory Affairs Manager Americas for Lallemand Health Solutions, said in a press release. “This lead to the publication of the first clinical study evaluating probiotics benefits on psychological symptoms of stress and anxiety as early as 2010.”
Previously, approved claims included generic probiotic claims such as a contribution to natural healthy gut flora.
“Such specific claims are the achievement of great team work. We are confident that they will help us not only in Canada but also in other territories to support our customers position in an expanding and competitive market,” said Celia Martin, Head of Regulatory Affairs, in a press release.
The company conducted a clinical trial back in 2013 to provide empirical evidence to its claim, which can be found here.
